Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,368 public trials 2,841 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

Pacritinib vs. Hydroxyurea in Advanced Proliferative Chronic Myelomonocytic Leukemia

NCT07033598

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +10 more
Locations: Moffitt Cancer Center Tampa, Florida, United States

Winship Cancer Institute at Emory Atlanta, Georgia, United States

Mayo Clinic Rochester Rochester, Minnesota, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Evaluating Myelodysplastic Syndrome Risks in NET Patients Planned for Peptide Radionuclide Therapy

NCT06510868

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Princess Margaret Cancer Centre Toronto, Ontario, Canada

View Trial Details

Recruiting

Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia

NCT03214562

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, High Risk Myelodysplastic Syndrome, +7 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Revumenib for the Treatment of Acute Leukemia in Patients Post-Allogeneic Stem Cell Transplant

NCT06575296

Conditions: Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Recruiting

Study Evaluating Combination of Luspatercept in LR-MDS Without RS Having Failed or Being Ineligible to ESA

NCT05181735

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: CHU Amiens-Picardie Amiens, France

Clinique de l'Europe Amiens, France

CHU Angers Angers, France

Centre Hospitalier Victor Dupouy Argenteuil, France

View all 40 locations

View Trial Details

Recruiting

Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia

NCT04984551

Conditions: Advanced Malignant Solid Neoplasm, Hematologic Diseases, Hematologic Neoplasms, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma

NCT05091372

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]

NCT06923111

Conditions: Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +7 more
Locations: Universitätsklinikum Hamburg-Eppendorf Hamburg, Germany

Universitätsklinikum Heidelberg Heidelberg, Germany

Basildon University Hospital Basildon, United Kingdom

Noah's Ark Children's Hospital for Wales Cardiff, United Kingdom

View Trial Details

Recruiting

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

NCT02464696

Conditions: Hematologic Diseases, Hematologic Neoplasms, Hematopoietic and Lymphoid Cell Neoplasm, +4 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML

NCT07451912

Conditions: Acute Myeloid Leukemia (AML), CEBPA Mutation, Hematologic Diseases, +7 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions